Company / Net Debt per Share
Twist Bioscience Corp Net Debt per Share History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$2.35
FY2020
5-year range
-
FY2018-FY2020
Trend
-52.7%
vs FY2019
Sector context
#70 of 85
Health Care
What the data says
Twist Bioscience Corp's net debt per share of $-2.35 is lower than 82% of companies in the Health Care sector (FY2020). Increased from $-26329.75 to $-2.35 over the past 2 years.
Based on SEC 10-K filings.
-2.35 in FY2020.
Increased from $-26329.75 to $-2.35 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 85This company -$2.35 Sector average $1.18
▼
-300.3% below sector average
Key checks
Key Insights
- In FY2020, net debt per share decreased 52.7% year-over-year.
- Ranks #70 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -$2.35 | -52.7% |
| FY2019 | -$1.54 | +100.0% |
| FY2018 | -$26329.75 | - |
| FY2017 | - | - |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026